Section 182-50-200. Endorsing practitioner therapeutic interchange program; effect of practitioner's endorsing status; dispense as written instructions.

(1) When filling prescriptions for participating state purchased health care programs, pharmacists must make a therapeutic interchange if the prescription is prescribed by an endorsing practitioner except:

(a) If the endorsing practitioner indicates "dispense as written" on the nonpreferred prescription;

(b) If the prescription is a refill of an antipsychotic, antidepressant, antiepileptic, chemotherapy, antiretroviral, immunosuppressive drug, or an immunomodulator/antiviral treatment for hepatitis C; or

(c) If the pharmacy and therapeutics committee has determined that therapeutic interchange is not clinically appropriate for a specific drug or drug class on the Washington preferred drug list.

(2) When a therapeutic interchange is made, the pharmacist must notify the endorsing practitioner of the specific drug and dose dispensed.

[Statutory Authority: RCW 41.05.021, 41.05.160, and 69.41.190. WSR 16-16-083, § 182-50-200, filed 7/29/16, effective 8/29/16. Statutory Authority: RCW 41.05.160 and 69.41.180. WSR 07-19-031 (Order 07-03), § 182-50-200, filed 9/12/07, effective 10/13/07. Statutory Authority: RCW 41.05.160; 2004 1st sp.s. c 29 § 10. WSR 04-06-021 (Order 03-02), § 182-50-200, filed 2/23/04, effective 3/25/04.]

RCW 41.05.021, 41.05.160, and 69.41.190. WSR 16-16-083, § 182-50-200, filed 7/29/16, effective 8/29/16. Statutory Authority: RCW 41.05.160 and 69.41.180. WSR 07-19-031 (Order 07-03), § 182-50-200, filed 9/12/07, effective 10/13/07. Statutory Authority: RCW 41.05.160; 2004 1st sp.s. c 29 § 10. WSR 04-06-021 (Order 03-02), § 182-50-200, filed 2/23/04, effective 3/25/04.